A - 118 Tablet-Based Cognitive Assessment Demonstrates Valid Assessment of Prodromal Huntington’s Disease

Abstract Objectives We analyzed performances on novel iPad-based assessments between at-risk gene-negative controls and participants carrying the gene causing Huntington’s Disease. TabCAT (UCSF) is used to detect mild cognitive impairment and dementia. We evaluated sensitivity in ten TabCAT assessments targeting memory, executive function, motor, and visuospatial abilities in 137 participants. We evaluated TabCAT’s effectiveness in detecting impairment in participants and assessed reliability of one test (Tempo) compared to a standard instrument (Paced Tapping). Methods Cytosine-adenine-guanine trinucleotide repeat length gene multiplied by age (CAG by age product (CAP) score) measured disease progression, based on estimated probability of manifesting motor symptoms (31 low, 41 moderate, 36 high). Controls were genetic relatives who tested negative. All statistical tests used an alpha level of 0.05. Results Significant differences were found for Favorites Learning, Favorites Delay, Flanker, and Match. Variables showed similar worsening trends from low to high; however, only differences with the high group were significant. The standardized Cronbach Coefficient Alphas were 0.68 for the first group of Paced Tapping variables, 0.91 for the second group, and 0.98 for Tempo. The standardized Cronbach Coefficient Alpha for variables of both tests was 0.82. Conclusions Grouping prodromal HD participants by disease risk compared to gene-negative controls enables cross-sectional analysis. High-risk participants performed significantly worse on tasks evaluating visual memory and executive functioning. Findings replicate previous publications showing that cognitive impairment worsens as one’s risk for motor symptom onset increases. Findings also suggest that the tablet-based assessment procedures reflect a valid representation of the insidious cognitive decline seen in traditional paper-and-pencil neuropsychological assessment.

Authors

Publication Details

Journal
Archives of Clinical Neuropsychology
Published
2024-09-12
DOI
https://doi.org/10.1093/arclin/acae067.132
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A - 118 Tablet-Based Cognitive Assessment Demonstrates Valid Assessment of Prodromal Huntington’s Disease

William Adams, Jane S. Paulsen, Katherine L. Possin, Deven K. Burks et al.
Archives of Clinical Neuropsychology
Genetic Neurodegenerative Diseases
article

A - 118 Tablet-Based Cognitive Assessment Demonstrates Valid Assessment of Prodromal Huntington’s Disease

William Adams, Jane S. Paulsen, Katherine L. Possin, Deven K. Burks, Alex Pinto, Abigail M. Key
article en

Abstract

Abstract Objectives We analyzed performances on novel iPad-based assessments between at-risk gene-negative controls and participants carrying the gene causing Huntington’s Disease. TabCAT (UCSF) is used to detect mild cognitive impairment and dementia. We evaluated sensitivity in ten TabCAT assessments targeting memory, executive function, motor, and visuospatial abilities in 137 participants. We evaluated TabCAT’s effectiveness in detecting impairment in participants and assessed reliability of one test (Tempo) compared to a standard instrument (Paced Tapping). Methods Cytosine-adenine-guanine trinucleotide repeat length gene multiplied by age (CAG by age product (CAP) score) measured disease progression, based on estimated probability of manifesting motor symptoms (31 low, 41 moderate, 36 high). Controls were genetic relatives who tested negative. All statistical tests used an alpha level of 0.05. Results Significant differences were found for Favorites Learning, Favorites Delay, Flanker, and Match. Variables showed similar worsening trends from low to high; however, only differences with the high group were significant. The standardized Cronbach Coefficient Alphas were 0.68 for the first group of Paced Tapping variables, 0.91 for the second group, and 0.98 for Tempo. The standardized Cronbach Coefficient Alpha for variables of both tests was 0.82. Conclusions Grouping prodromal HD participants by disease risk compared to gene-negative controls enables cross-sectional analysis. High-risk participants performed significantly worse on tasks evaluating visual memory and executive functioning. Findings replicate previous publications showing that cognitive impairment worsens as one’s risk for motor symptom onset increases. Findings also suggest that the tablet-based assessment procedures reflect a valid representation of the insidious cognitive decline seen in traditional paper-and-pencil neuropsychological assessment.

Archives of Clinical Neuropsychology
Openalex Percentile: Top 84%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A - 118 Tablet-Based Cognitive Assessment Demonstrates Valid Assessment of Prodromal Huntington’s Disease — William Adams, Jane S. Paulsen, et al. · Archives of Clinical Neuropsychology (2024) | TGRS Research Map | TGRS